Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Short-term Investments (2019 - 2021)

Historic Short-term Investments for Bio Key International (BKYI) over the last 4 years, with Q2 2021 value amounting to $512821.0.

  • Bio Key International's Short-term Investments changed 0.0% to $512821.0 in Q2 2021 from the same period last year, while for Jun 2021 it was $512821.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $512821.0 for FY2020, which is 0.0% changed from last year.
  • Bio Key International's Short-term Investments amounted to $512821.0 in Q2 2021, which was down 0.0% from $512821.0 recorded in Q1 2021.
  • Over the past 5 years, Bio Key International's Short-term Investments peaked at $516121.0 during Q3 2020, and registered a low of $512821.0 during Q3 2019.
  • Its 3-year average for Short-term Investments is $513233.5, with a median of $512821.0 in 2019.
  • Examining YoY changes over the last 5 years, Bio Key International's Short-term Investments showed a top increase of 64.35% in 2020 and a maximum decrease of 0.0% in 2020.
  • Quarter analysis of 3 years shows Bio Key International's Short-term Investments stood at $512821.0 in 2019, then changed by 0.0% to $512821.0 in 2020, then changed by 0.0% to $512821.0 in 2021.
  • Its Short-term Investments stands at $512821.0 for Q2 2021, versus $512821.0 for Q1 2021 and $512821.0 for Q4 2020.